GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Transpact Enterprises Ltd (BOM:542765) » Definitions » Debt-to-EBITDA

Transpact Enterprises (BOM:542765) Debt-to-EBITDA : -0.51 (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Transpact Enterprises Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Transpact Enterprises's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹0.29 Mil. Transpact Enterprises's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹0.00 Mil. Transpact Enterprises's annualized EBITDA for the quarter that ended in Sep. 2023 was ₹-0.56 Mil. Transpact Enterprises's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was -0.51.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Transpact Enterprises's Debt-to-EBITDA or its related term are showing as below:

BOM:542765' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -13.46   Med: -1.34   Max: -0.52
Current: -0.52

During the past 8 years, the highest Debt-to-EBITDA Ratio of Transpact Enterprises was -0.52. The lowest was -13.46. And the median was -1.34.

BOM:542765's Debt-to-EBITDA is ranked worse than
100% of 431 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs BOM:542765: -0.52

Transpact Enterprises Debt-to-EBITDA Historical Data

The historical data trend for Transpact Enterprises's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transpact Enterprises Debt-to-EBITDA Chart

Transpact Enterprises Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.70 -0.68 -13.46 -1.61 -9.28

Transpact Enterprises Semi-Annual Data
Mar16 Mar17 Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.65 3.34 -49.74 -5.14 -0.51

Competitive Comparison of Transpact Enterprises's Debt-to-EBITDA

For the Medical Devices subindustry, Transpact Enterprises's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transpact Enterprises's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Transpact Enterprises's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Transpact Enterprises's Debt-to-EBITDA falls into.



Transpact Enterprises Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Transpact Enterprises's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.785 + 0) / -0.3
=-9.28

Transpact Enterprises's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.289 + 0) / -0.562
=-0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2023) EBITDA data.


Transpact Enterprises  (BOM:542765) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Transpact Enterprises Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Transpact Enterprises's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Transpact Enterprises (BOM:542765) Business Description

Traded in Other Exchanges
N/A
Address
Makwana Road, 204, 2nd Floor, Timmy Arcade, Marol, Andheri East, Mumbai, MH, IND, 400059
Transpact Enterprises Ltd is an Indian company engaged in the manufacture of other medical and dental instruments. It operates only in India.

Transpact Enterprises (BOM:542765) Headlines

No Headlines